Literature DB >> 21174058

MicroRNA expression profiles in human colorectal cancers with liver metastases.

Maosong Lin1, Weichang Chen, Junxing Huang, Hengjun Gao, Yulan Ye, Zhenyun Song, Xiaoying Shen.   

Abstract

At present, a full understanding of the mechanisms by which colorectal cancer (CRC) distant metastases form is still beyond our reach because of the intricate regulation of gene expression. MicroRNAs (miRNAs) are shown to be involved in various human diseases including cancers through negative regulation of target gene expression at the post-transcriptional level. However, there are only a few studies on the roles of miRNA aberrations in liver metastasis of human colorectal cancer. To identify miRNA expression patterns associated with liver metastasis in human colorectal cancer, the miRNA expression profiles of colorectal cancer tissues with liver metastasis and their non-metastatic counterparts were studied using microRNA microarrays and further confirmed by quantitative RT-PCR. We show that 28 miRNAs are differentially expressed in the colorectal carcinomas with liver metastasis compared to the non-metastatic counterparts. Of these, 4 miRNAs including miR-150*, miR-125b-2*, miR-1179 and miR-139-3p were up-regulated in colorectal cancers with liver metastasis while the others were down-regulated. The target genes of selected deregulated miRNAs were predicted through bioinformatic techniques with two functional analyses, gene ontology and KEGG analysis, which showed that categories of high enrichment GOs and specific pathways targeted by dysregulated miRNAs were involved in liver metastasis during human colorectum carcinogenesis. Our results indicated that miRNAs are not only involved in carcinogenesis of colorectum, but may also participate in the progression such as with liver metastases in human colorectal cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21174058     DOI: 10.3892/or.2010.1112

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  36 in total

1.  Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer.

Authors:  Mao-Song Lin; Wei-Chang Chen; Jun-Xing Huang; Heng-Jun Gao; Hai-Hui Sheng
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a.

Authors:  Jiaojiao Zhou; Mengwen Zhang; Yanqing Huang; Lin Feng; Hailong Chen; Yiwang Hu; Huarong Chen; Kaitai Zhang; Lei Zheng; Shu Zheng
Journal:  Cancer Lett       Date:  2014-10-16       Impact factor: 8.679

3.  miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.

Authors:  Guopeng Yu; Qianyi Xiao; Xiao-Pin Ma; Xubo Chen; Zhuqing Shi; Lu-Yao Zhang; Haitao Chen; Pengyin Zhang; Dong-Lin Ding; Hui-Xing Huang; Hexige Saiyin; Tao-Yang Chen; Pei-Xin Lu; Neng-Jin Wang; Hongjie Yu; Jielin Sun; Carly Conran; S Lilly Zheng; Jianfeng Xu; Long Yu; De-Ke Jiang
Journal:  Tumour Biol       Date:  2016-01-11

4.  Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells.

Authors:  Zhong-Dong Wang; Fan-Yong Qu; Yuan-Yuan Chen; Zhang-Shen Ran; Hai-Yan Liu; Hai-Dong Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2017 Jan.       Impact factor: 3.066

5.  Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis.

Authors:  Ma Yuxia; Tian Zhennan; Zhang Wei
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-18       Impact factor: 4.553

6.  MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.

Authors:  Sanjeev K Srivastava; Arun Bhardwaj; Seema Singh; Sumit Arora; Bin Wang; William E Grizzle; Ajay P Singh
Journal:  Carcinogenesis       Date:  2011-10-07       Impact factor: 4.944

7.  MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F transcription factor 5.

Authors:  Xiupeng Xu; Ning Cai; Tongle Zhi; Zhongyuan Bao; Dong Wang; Yinlong Liu; Kuan Jiang; Liang Fan; Jing Ji; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

8.  Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.

Authors:  Matthias Dettmer; Aurel Perren; Holger Moch; Paul Komminoth; Yuri E Nikiforov; Marina N Nikiforova
Journal:  Thyroid       Date:  2013-09-19       Impact factor: 6.568

9.  microRNA expression profiles in human colorectal cancers with brain metastases.

Authors:  Zhenyang Li; Xiaodong Gu; Yantian Fang; Jianbin Xiang; Zongyou Chen
Journal:  Oncol Lett       Date:  2011-11-29       Impact factor: 2.967

10.  miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened.

Authors:  Kai Sun; Hai-Jun Deng; Shang-Tong Lei; Jing-Qing Dong; Guo-Xin Li
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.